Clincosm LogoSign in Get a demo

Stage III Renal Cell Cancer

Showing 1 - 25 of 29
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer Trial in New Brunswick (Arterial Spin

Completed
  • Stage I Renal Cell Cancer
  • +3 more
  • Arterial Spin Labeling Magnetic Resonance Imaging
  • +3 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Oct 14, 2022

Advanced Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Seattle (Aldesleukin,

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 5, 2022

Stage II Renal Cell Cancer, Stage III Renal Cell Cancer Trial (tivozanib, therapeutic conventional surgery)

Withdrawn
  • Stage II Renal Cell Cancer
  • Stage III Renal Cell Cancer
  • (no location specified)
Aug 11, 2022

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Buffalo, New York
  • +1 more
Aug 11, 2022

Infiltrating Bladder Urothelial Carcinoma, Recurrent Bladder Carcinoma, Stage I Prostate Cancer Trial in Los Angeles (other,

Terminated
  • Infiltrating Bladder Urothelial Carcinoma
  • +9 more
  • Cytology Specimen Collection Procedure
  • +4 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 15, 2021

Myeloid Derived Suppressor Cells Clinical Assay in Finding

Recruiting
  • Healthy Subject
  • +5 more
  • Computed Tomography
  • +3 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 16, 2021

Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Bronx, New York (vorinostat,

Terminated
Has Results
  • Recurrent Renal Cell Cancer
  • +2 more
  • Bronx, New York
  • +1 more
Feb 1, 2021

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +44 more
  • fludarabine phosphate
  • +9 more
  • Duarte, California
  • +6 more
Sep 6, 2019

Magnetic Resonance Imaging in Predicting Response to Sunitinib

Completed
  • Renal Cell Carcinoma
  • +2 more
  • mutation analysis
  • +5 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Jun 21, 2019

Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory

Completed
  • Advanced Malignant Neoplasm
  • +31 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
  • +1 more
Jun 5, 2019

Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in United States (Erlotinib

Completed
Has Results
  • Recurrent Renal Cell Carcinoma
  • +4 more
  • Erlotinib Hydrochloride
  • +2 more
  • Tucson, Arizona
  • +213 more
Dec 12, 2018

B-Cell Tumor, Estrogen Receptor Negative, HER2/Neu Negative Trial in Stanford (18F-FSPG, 18F-FDG)

Completed
Has Results
  • B-Cell Neoplasm
  • +15 more
  • Stanford, California
    Stanford University Medical Center
Dec 11, 2018

Renal Cancer Patients Treated by Non-IV Drugs

Unknown status
  • Metastatic Renal Cancer
  • Stage III Renal Cell Cancer
  • observance of oral drug treatment
  • Angers, France
  • +13 more
Oct 11, 2018

Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer Trial in Cleveland, Philadelphia

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • pazopanib hydrochloride
  • therapeutic conventional surgery
  • Cleveland, Ohio
  • +1 more
Aug 17, 2018

Recurrent Melanoma, Recurrent Pancreatic Cancer, Recurrent Renal Cell Cancer Trial in Winston-Salem (siRNA-transfected

Completed
  • Recurrent Melanoma
  • +11 more
  • siRNA-transfected peripheral blood mononuclear cells APN401
  • laboratory biomarker analysis
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jul 2, 2018

Adult Solid Tumor, Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma Trial in Madison (Computed Tomography,

Completed
  • Adult Solid Neoplasm
  • +4 more
  • Computed Tomography
  • +5 more
  • Madison, Wisconsin
    University of Wisconsin Hospital and Clinics
Oct 9, 2017

Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma, Recurrent Non-Small Cell Lung Carcinoma Trial in

Completed
  • Head and Neck Squamous Cell Carcinoma
  • +13 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Palo Alto, California
  • +4 more
Sep 14, 2017

Childhood Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Clear Cell Sarcoma of the Kidney Trial in Worldwide (drug,

Completed
Has Results
  • Childhood Renal Cell Carcinoma
  • +12 more
  • Doxorubicin Hydrochloride
  • +9 more
  • Birmingham, Alabama
  • +186 more
Jun 22, 2017

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Baltimore, Salisbury, Madison

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Baltimore, Maryland
  • +2 more
Dec 10, 2015

Adult Solid Tumor, Lung Carcinoid Tumor, Recurrent Digestive System Neuroendocrine Tumor G1 Trial in Vancouver, Hamilton,

Completed
  • Adult Solid Neoplasm
  • +10 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Vancouver, British Columbia, Canada
  • +2 more
Oct 5, 2015

Recurrent Renal Cell Cancer, Renal Cell Carcinoma, Stage III Renal Cell Cancer Trial in United States (etaracizumab,

Terminated
Has Results
  • Recurrent Renal Cell Cancer
  • +3 more
  • Marysville, California
  • +4 more
Apr 28, 2014

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage I Renal Cell Cancer Trial in Baltimore, Madison (drug,

Completed
  • Clear Cell Renal Cell Carcinoma
  • +6 more
  • sunitinib malate
  • +6 more
  • Baltimore, Maryland
  • +1 more
Apr 1, 2014

Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Recurrent Renal Cell Cancer Trial in Durham (drug, biological,

Terminated
  • Clear Cell Renal Cell Carcinoma
  • +4 more
  • sorafenib tosylate
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Jul 1, 2013

Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Chicago (ispinesib)

Completed
  • Recurrent Renal Cell Cancer
  • +2 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jun 4, 2013

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Chicago (ixabepilone,

Completed
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Mar 22, 2013